AI and Biotechnology – these two super technologies are combining – World Economic Forum

Financial analysts recognize the massive growth potential of artificial intelligence and biotechnology. But, if anything, the likely economic impact of these sectors is being underestimated, because few have reckoned with the implications of what...

IDT releases new ultra-high performance CRISPR Cas12a enzyme

May 31 2019 As an advocate for the needs of researchers working at the forefronts of genomic research, Integrated DNA Technologies (IDT) releases its latest CRISPR enzyme Alt-R® Cas12a (Cpf1) Ultra. Cas12a Ultra is a...

Study pinpoints brain cells that trigger sugar cravings and consumption

Credit: Matthew Potthoff, University of Iowa Carver College of Medicine New research has identified the specific brain cells that control how much sugar you eat and how...

VarmX bags €32m in Series B round – European Biotechnology News

Leiden-based coagulant developer VarmX NV has closed a €32m Series B financing to push the Phase II development of VMX-C001, a venom-based modified recombinant Factor X. New investors LSP, Ysios Capital, INKEF Capital and Lundbeckfonden...

Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development

/* custom css */ .td_uid_1_5e957a936089d_rand { min-height: 0; } /* custom css */ .td_uid_2_5e957a9360a9b_rand { vertical-align: baseline; } While President Trump continues to promote antimalarial drugs such as hydroxychloroquine sulfate and azithromycin to treat COVID-19—“What do...

Genexine and NeoImmuneTech (NIT) – GX-I7 [also called NT-17 or Hyleukin-7™ (rhIL-7-hyFc)]

Candidate: GX-I7, also known as NT-17 or Hyleukin-7 (rhIL-7-hyFc) Type: Homeostatic T cell growth factor composed of a covalently linked homodimer of engineered Interleukin-7 (IL-7) molecule, biologically fused with the proprietary long-acting platform – hyFc....

China Pursuing ‘Aggressive’ Biotechnology Strategy – National Defense Magazine

iStock illustration As rapid innovation in computer sciences helps bolster advances in biotechnologies, China is edging forward as a world leader in the biotech sector, one expert said. “Biotechnologies, including synthetic biology, are going to be...

First COVID-19 vaccine found to be safe, able to generate rapid immune response in...

Reviewed by Emily Henderson, B.Sc.May 22 2020 The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans,...

Volunteers can now register for coronavirus disease vaccine trials

As the world grapples with the coronavirus pandemic, many pharmaceutical companies, and research organizations are racing to develop an effective vaccine against the novel coronavirus, called the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Human...

Salmonella biofilm protein can cause autoimmune responses, arthritis in animals

Scientists from the Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) at the University of Saskatchewan (USask) and Temple University (Philadelphia, U.S.) have demonstrated that a Salmonella biofilm protein can cause autoimmune responses and...

Stay connected

52,371FollowersFollow
14,700SubscribersSubscribe

Recent posts

Random article